GLMD (Galmed Pharmaceuticals) Pretax Margin %: % (As of Dec. 2025)

What is Galmed Pharmaceuticals Pretax Margin %?

Galmed Pharmaceuticals GLMD +2.71% 27 Pretax Margin % is % as of Dec. 2025. GuruFocus rates GLMD with a GF Score™ of 27/100. The stock has 2 warning signs investors should review. Among 947 Biotechnology companies, Galmed Pharmaceuticals ranks worse than 105596.52% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Galmed Pharmaceuticals's Pre-Tax Income for the three months ended in Dec. 2025 was $-4.82 Mil. Galmed Pharmaceuticals's Revenue for the three months ended in Dec. 2025 was $0.00 Mil. Therefore, Galmed Pharmaceuticals's pretax margin for the quarter that ended in Dec. 2025 was %.

The historical rank and industry rank for Galmed Pharmaceuticals's Pretax Margin % or its related term are showing as below:

GLMD's Pretax Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -92.22
* Ranked among companies with meaningful Pretax Margin % only.

Galmed Pharmaceuticals (NAS:GLMD) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Galmed Pharmaceuticals Pretax Margin % Related Terms

Galmed Pharmaceuticals Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Galmed Pharmaceuticals's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galmed Pharmaceuticals Pretax Margin % Chart

Galmed Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Pretax Margin %

Get a 7-Day Free Trial

0.00

Galmed Pharmaceuticals Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
Pretax Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

GLMD vs RNAZ, ARTL, CDT: Pretax Margin % Comparison

For the Biotechnology subindustry, Galmed Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galmed Pharmaceuticals Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galmed Pharmaceuticals's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Galmed Pharmaceuticals's Pretax Margin % falls into.

Save Embed

27GF Score

Galmed Pharmaceuticals Ltd GLMD

Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Galmed Pharmaceuticals Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Galmed Pharmaceuticals's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-10.309	/	0
	=	%

Galmed Pharmaceuticals's Pretax Margin for the quarter that ended in Dec. 2025 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	-4.818	/	0
	=	%

Frequently Asked Questions Learn more about Pretax Margin % →

What does a Pretax Margin % of % mean?

Galmed Pharmaceuticals (GLMD) has a Pretax Margin % of % as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Galmed Pharmaceuticals and its competitors. According to the industry distribution chart, Galmed Pharmaceuticals ranks #999999 out of 947 companies in the Biotechnology industry.

Is Galmed Pharmaceuticals' Pretax Margin % too high?

Galmed Pharmaceuticals' current Pretax Margin % is %. Based on the distribution chart, Galmed Pharmaceuticals ranks #999999 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Galmed Pharmaceuticals has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.

How does Galmed Pharmaceuticals' Pretax Margin % compare to RNAZ and ARTL?

According to the Biotechnology industry distribution chart, Galmed Pharmaceuticals ranks #999999 out of 947 companies for Pretax Margin %. This places Galmed Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Pretax Margin % for a Biotechnology company?

A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Pretax Margin % mean?

A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Galmed Pharmaceuticals and its competitors. Galmed Pharmaceuticals's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Galmed Pharmaceuticals stock overvalued right now?

Galmed Pharmaceuticals (GLMD) has a current Pretax Margin % of %. The current Pretax Margin % is %. Galmed Pharmaceuticals' overall GF Score™ is 27/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Pretax Margin % calculated?

Pretax Margin % is calculated from a company's financial statements. For Galmed Pharmaceuticals (GLMD), the current Pretax Margin % is % as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galmed Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies RNAZ ARTL CDT PULM ADIL MBIO DCOY MTNB DRMA RVPH VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address c/o Meitar Law Offices, 16 Abba Hillel Road, Ramat Gan, ISR, 5250608

Website https://www.galmedpharma.com

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.

27GF Score

Get the complete analysis for GLMD

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.59

Price

View GLMD Analysis

See Pretax Margin % data for all stocks →